Anacor Pharmaceuticals, Inc.·4

Dec 3, 7:09 PM ET

Anacor Pharmaceuticals, Inc. 4

4 · Anacor Pharmaceuticals, Inc. · Filed Dec 3, 2014

Insider Transaction Report

Form 4
Period: 2014-12-01
Plattner Jacob j
Senior VP Research
Transactions
  • Sale

    Common Stock

    2014-12-01$34.08/sh900$30,67265,225 total(indirect: See Footnote)
  • Sale

    Common Stock

    2014-12-01$33.23/sh5,975$198,56566,125 total(indirect: See Footnote)
Footnotes (4)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2014.
  • [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.82, inclusive.
  • [F3]These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.
  • [F4]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $33.97 to $34.16, inclusive.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION